Decreased neural damage after spinal cord injury in tPA-deficient mice

Journal of Neurotrauma

Volumn 20, Issue 1, 2003, Pages 43-57

  Abe, Yumiko ^a   Nakamura, Hiroshi ^a   Yoshino, Osamu ^a   Oya, Takeshi ^a   Kimura, Tomoatsu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Apoptosis; Knock out mouse; Microglia; Motor evoked potentials; Serine protease; Spinal cord injury; Tissue plasminogen activator

Indexed keywords

DYE; MYELIN BASIC PROTEIN; NEUROFILAMENT PROTEIN; PLASMIN; PLASMINOGEN; SERINE PROTEINASE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ELECTROPHYSIOLOGY; EVOKED MUSCLE RESPONSE; HINDLIMB; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LOCOMOTION; MACROPHAGE ACTIVATION; MALE; MICROGLIA; MOUSE; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NERVE INJURY; NEUROPATHOLOGY; NONHUMAN; PROTEIN SYNTHESIS; SPINAL CORD INJURY; STAINING; WHITE MATTER;

EID: 0037263651     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/08977150360517173     Document Type: Article

References (62)

1. AHMED, Z., GVERIC, D., PRYCE, G., et al. (2001). Myelin/axonal pathology in interleukin-12 induced serial relapses of experimental allergic encephalomyelitis in the Lewis rat. Am. J. Pathol. 158, 2127-2138.
2. AKASSOGLOU, K., KOMBRINCK, K.W., DEGEN, J.L., et al. (2000). Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury. J. Cell Biol. 149, 1157-1166.
3. ALEXANDER, C.M., and WERB, Z. (1989). Proteinases and extracellular matrix remodeling. Curr. Opin. Cell Biol. 1, 974-982.
4. ANDERSSON, P.B., PERRY, V.H., and GORDON, S. (1991). The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration. Neuroscience 42, 201-214.
5. AUSTYN, J.M., and GORDON, S. (1981). F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11, 805-815.
6. BANIK, N.L., HOGAN, E.L., POWERS, J.M., et al. (1986). Proteolytic enzymes in experimental spinal cord injury. J. Neurol. Sci. 73, 245-256.
7. BARANES, D., LEDERFEIN, D., HUANG, Y.Y., et al. (1998). Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron 21, 813-825.
8. BASSO, D.M., BEATTIE, M.S., and BRESNAHAN, J.C. (1995). A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1-21.
9. BHAT, R.V., DIROCCO, R., MARCY, V.R., et al. (1996). Increased expression of IL-1β converting enzyme in hippocampus after ischemia: Selective localization in microglia. J. Neurosci. 16, 4146-4154.
10. BINGHAM, W.G., GOLDMAN, H., FRIEDMAN, S.J., et al. (1975). Boood flow in normal and injured monkey spinal cord. J. Neurosurg. 43, 162-171.
11. CAMMER, W., BLOOM, B.R., NORTON, W.T., et al. (1978). Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. Proc. Natl. Acad. Sci. USA 75, 1554-1558.
12. CARMELIET, P., SCHOONJANS, L., KIECKENS, L., et al. (1994). Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368, 419-424.
13. CHEN, Z.L., and STRICKLAND, S. (1997). Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91, 917-925.
14. COLLEN, D., and LIJNEN, H.R. (1991). Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 78, 3114-3124.
15. COMBS, C.K., KARLO, J.C., KAO, S.C., et al. (2001). β-Amyloid stimulation of microglia and monocytes results in TNF α-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 21, 1179-1188.
16. CROWE, M.J., BRESNAHAN, J.C., SHUMAN, S.L., et al. (1997). Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3, 73-76.
17. CUZNER, M.L., GVERIC, D., and STRAND, C. (1996). The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J. Neuropathol. Exp. Neurol. 55, 1194-1204.
18. DANGLOT, G., VINSON, D., and CHAPEVILLE, F. (1986). Qualitative and quantitative distribution of plasminogen activators in organs from healthy adult mice. FEBS. Lett. 194, 96-100.
19. ELLIS, R.E., YUAN, J., and HORVITZ, H.R. (1991). Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7, 663-698.
20. ENDO, A., NAGAI, N., URANO, T., et al. (1999). Proteolysis of neuronal cell adhesion molecule by the tissue plasminogen activator-plasmin system after kainate injection in the mouse hippocampus. Neurosci. Res. 33, 1-8.
21. FADEN, A.I., and SIMON, R.P. (1988). A potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann. Neurol. 23, 623-626.
22. FLAVIN, M.P., ZHAO, G., and HO, L.T. (2000). Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro. Glia 29, 347-354.
23. GAVRIELI, Y., SHERMAN, Y., and BEN-SASSSON, S.A. (1992), Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501.
24. GHALY, R.F., STONE, J.L., ALDRETE, J.A., et al. (1990). Effects of incremental ketamine hydrochloride doses on motor evoked potentials (MEPs) following transcranial magnetic stimulation: a primate study. J. Neurosurg. Anesthesiol. 2, 79-85.
25. GRUNER, J.A., WADE,C.K., MENNA, G., et al. (1993). Myoelectric evoked potentials versus locomotor recovery in chronic spinal cord injured rats. J. Neurotrauma 10, 327-347.
26. GUALANDRIS, A., JONES, T.E., STRICKLAND, S., et al. (1996). Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator. J. Neurosci. 16, 2220-2225.
27. GUTH, L., ZHANG, Z., DIPROSPERO, N.A., et al. (1994). Spinal cord injury in the rat: treatment with bacterial lipopolysaccharide and indomethacin enhances cellular repair and locomotor function. Exp. Neurol. 126, 76-87.
28. KIM, Y.H., PARK, J.H., HONG, S.H., et al. (1999). Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator. Science 284, 647-650.
29. KITAGAWA, H., NAKAMURA, H., KAWAGUCHI, Y., et al. (1995). Magnetic-evoked compound muscle action potential neuromonitoring in spine surgery. Spine 20, 2233-2239.
30. KREUTZBERG, G.W. (1996). Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318.
31. KRYSTOSEK, A., and SEEDS, N.W. (1981). Plasminogen activator release at the neuronal growth cone. Science 213, 1532-1534.
32. KUHN, P.L., and WRATHALL, J.R. (1998). A mouse model of graded contusive spinal cord injury. J. Neurotrauma 15, 125-140.
33. LIU, X.Z., XU, X.M., HU, R., et al. (1997). Neuronal and glial apoptosis after traumatic spinal cord injury. J. Neurosci. 17, 5395-5406.
34. LOY, D.N., MAGNUSON, D.S.K., ZHANG, Y.P., et al. (2002). Functional redundancy of ventral spinal locomotor pathways. J. Neurosci. 22, 315-323.
35. MANNUCCI, P.M., ABERG, M., NILSSON, I.M., et al. (1975). Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br. J. Haematol. 30, 81-93.
36. MILVY, P., KAKARI, S., CAMPBELL, J.B., et al. (1973). Paramagnetic species and radical products in cat spinal cord. Ann. NY Acad. Sci. 222, 1102-1111.
37. MOONEN, G., GRAU-WAGEMANS, M.P., and SELAK, I. (1982). Plasminogen activator-plasmin system and neuronal migration. Nature 298, 753-755.
38. MUN-BRYCE, S., and ROSENBERG, G.A. (1998). Matrix metalloproteinases in cerebrovascular disease. J. Cereb. Blood Flow Metab. 18, 1163-1172.
39. NASHMI, R., IMAMURA, H., TATOR, C.H., et al. (1997). Serial recording of somatosensory and myoelectric motor evoked potentials: role in assessing functional recovery after graded spinal cord injury in the rat. J. Neurotrauma 14, 151-159.
40. NICOLE, O., DOCAGNE, F., ALI, C., et al. (2001). The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat. Med. 7, 59-64.
41. PERRY, V.H., and GORDON, S. (1988). Macrophages and microglia in the nervous system. Trends Neurosci. 11, 273-277.
42. POPOVICH, P. G., WEI, P., and STOKES, B.T. (1997). Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377, 443-464.
43. QIAN, Z., GILBERT, M.E., COLICOS, M.A., et al. (1993). Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature 361, 453-457.
44. REESE, T.S., and KARNOVSKY, M.J. (1967). Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 34, 207-217.
45. ROGOVE, A.D., SIAO, C.J., KEYT, B., et al. (1999). Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system. J. Cell Sci. 112, 4007-4016.
46. SCARISBRICK, I.A., TOWNER, M.D., and ISACKSON, P.J. (1997). Nervous system-specific expression of a novel serine protease: regulation in the adult rat spinal cord by excitotoxic injury. J. Neurosci. 17, 8156-8168.
47. SEEDS, N.W., WILLIAMS, B.L., and BICKFORD, P.C. (1995). Tissue plasminogen activator induction in Purkinje neurons after cerebellar motor learning. Science 270, 1992-1994.
48. SHERRY, S., LINDEMEYER, R.I., FLETCHER, A.P., et al. (1959). Studies on enhanced fibrinolytic activity in man. J. Clin. Invest. 38, 810-822.
49. SICONOLFI, L.B., and SEEDS, N.W. (2001a). Induction of the plasminogen activator system accompanies peripheral nerve regeneration after sciatic nerve crush. J. Neurosci. 21, 4336-4347.
50. SICONOLFI, L.B., and SEEDS, N.W. (2001b). Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush. J. Neurosci. 21, 4348-4355.
51. SPRINGER, J.E., AZBILL, R.D., and KNAPP, P.E. (1999). Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat. Med. 5, 943-946.
52. STERNBERGER, L.A., and STERNBERGER, N.H. (1983). Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc. Natl. Acad. Sci. USA 80, 6126-6130.
53. STEWARD, O., SCHAUWECKER, P.E., GUTH, L., et al. (1999). Genetic approaches to neurotrauma research: opportunities and potential pitfalls of murine models. Exp. Neurol. 157, 19-42.
54. SUMI, Y., DENT, M.A.R., OWEN, D.E., et al. (1992). The expression of tissue and urokinase-type plasminogen activators in neural development suggests different modes of proteolytic involvement in neuronal growth. Development 116, 625-637.
55. TATOR, C.H., and FEHLINGS, M.G. (1991). Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75, 15-26.
56. TSIRKA, S.E., GUALANDRIS, A., AMARAL, D.G., et al. (1995). Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377, 340-344.
57. TSIRKA, S.E. (1997a). Clinical implications of the involvement of tPA in neuronal cell death. J. Mol. Med, 75, 341-347.
58. TSIRKA, S.E., ROGOVE, A.D., BUGGE, T.H., et al. (1997b). An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J. Neurosci. 17, 543-552.
59. WRATHALL, J.R., TENG, Y.D., CHOINIERE, D., et al. (1992). Evidence that local non-NMDA receptors contribute to functional deficits in contusive spinal cord injury. Brain Res. 586, 140-143.
60. YOUNG, W., and KOREH, I. (1986). Potassium and calcium changes in injured spinal cords. Brain Res. 365, 42-53.
61. s) that causes delayed wallerian degeneration. J. Comp. Neurol. 371, 485-495.
62. ZHANG, Z., and GUTH, L. (1997). Experimental spinal cord injury: Wallerian degeneration in the dorsal column is followed by revascularization, glial proliferation, and nerve regeneration. Exp. Neurol. 147, 159-171.